12/19
08:43 am
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
Low
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
12/19
08:07 am
clnn
Clene Improves Cash Position and Runway by Securing New Debt Facility to Pay Off Existing Senior Loan [Yahoo! Finance]
Medium
Report
Clene Improves Cash Position and Runway by Securing New Debt Facility to Pay Off Existing Senior Loan [Yahoo! Finance]
12/19
08:00 am
clnn
Clene Improves Cash Position and Runway by Securing New Debt Facility to Pay Off Existing Senior Loan
Low
Report
Clene Improves Cash Position and Runway by Securing New Debt Facility to Pay Off Existing Senior Loan
12/11
11:33 am
clnn
IBN Coverage: Clene (NASDAQ: CLNN) Advances CNM-Au8 in ALS With FDA Guidance on Accelerated Approval Pathway [Yahoo! Finance]
Neutral
Report
IBN Coverage: Clene (NASDAQ: CLNN) Advances CNM-Au8 in ALS With FDA Guidance on Accelerated Approval Pathway [Yahoo! Finance]
12/10
09:44 am
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
Medium
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
12/10
08:42 am
clnn
FDA Provides Roadmap for Accelerated Approval Pathway Through Submission of Additional CNM-Au8® Biomarker Data in ALS [Yahoo! Finance]
High
Report
FDA Provides Roadmap for Accelerated Approval Pathway Through Submission of Additional CNM-Au8® Biomarker Data in ALS [Yahoo! Finance]
12/10
08:30 am
clnn
FDA Provides Roadmap for Accelerated Approval Pathway Through Submission of Additional CNM-Au8® Biomarker Data in ALS
Low
Report
FDA Provides Roadmap for Accelerated Approval Pathway Through Submission of Additional CNM-Au8® Biomarker Data in ALS
11/22
10:19 am
clnn
Clene Inc. (NASDAQ: CLNN) had its price target lowered by analysts at Benchmark Co. from $90.00 to $84.00. They now have a "buy" rating on the stock.
Low
Report
Clene Inc. (NASDAQ: CLNN) had its price target lowered by analysts at Benchmark Co. from $90.00 to $84.00. They now have a "buy" rating on the stock.
11/14
11:13 am
clnn
Clene Inc. (NASDAQ: CLNN) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $86.00 to $83.00. They now have a "buy" rating on the stock.
Medium
Report
Clene Inc. (NASDAQ: CLNN) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $86.00 to $83.00. They now have a "buy" rating on the stock.
11/14
08:15 am
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
Medium
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
11/13
10:21 am
clnn
Clene Inc. (CLNN) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]
Low
Report
Clene Inc. (CLNN) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]
11/13
08:00 am
clnn
Clene Reports Third Quarter 2024 Financial Results and Recent Operating Highlights
Medium
Report
Clene Reports Third Quarter 2024 Financial Results and Recent Operating Highlights
10/24
08:08 am
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
Low
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
10/21
01:38 pm
clnn
IBN Coverage: Clene (NASDAQ: CLNN) Presents Lead Candidate CNM-Au8(R) Updates at Investor Conferences [Yahoo! Finance]
Medium
Report
IBN Coverage: Clene (NASDAQ: CLNN) Presents Lead Candidate CNM-Au8(R) Updates at Investor Conferences [Yahoo! Finance]
10/11
03:13 pm
clnn
IBN Coverage: Clene (NASDAQ: CLNN) Closes $7.3M Registered Direct Offering and Concurrent Private Placements [Yahoo! Finance]
Low
Report
IBN Coverage: Clene (NASDAQ: CLNN) Closes $7.3M Registered Direct Offering and Concurrent Private Placements [Yahoo! Finance]
10/9
08:00 am
clnn
Clene to Present at Upcoming October Conferences
High
Report
Clene to Present at Upcoming October Conferences
10/5
10:09 am
clnn
Independent Chairman of the Board of Clene David Matlin Buys 26% More Shares [Yahoo! Finance]
Low
Report
Independent Chairman of the Board of Clene David Matlin Buys 26% More Shares [Yahoo! Finance]
10/4
11:36 am
clnn
Clene Inc. (NASDAQ: CLNN) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $94.00 to $86.00. They now have a "buy" rating on the stock.
Medium
Report
Clene Inc. (NASDAQ: CLNN) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $94.00 to $86.00. They now have a "buy" rating on the stock.
10/3
10:58 am
clnn
IBN Coverage: Clene (NASDAQ: CLNN) Closes on Direct Offering, Concurrent Private Placements Totaling $7.3M [Yahoo! Finance]
Low
Report
IBN Coverage: Clene (NASDAQ: CLNN) Closes on Direct Offering, Concurrent Private Placements Totaling $7.3M [Yahoo! Finance]
10/2
07:37 am
clnn
IBN Coverage: Clene (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements [Yahoo! Finance]
Medium
Report
IBN Coverage: Clene (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements [Yahoo! Finance]
10/1
04:00 pm
clnn
Clene Announces Closing of $7.3 Million Registered Direct Offering and Concurrent Private Placements and Amendment of Debt Facility
Medium
Report
Clene Announces Closing of $7.3 Million Registered Direct Offering and Concurrent Private Placements and Amendment of Debt Facility
9/30
08:58 am
clnn
Clene launches $7.3M registered direct offering [Seeking Alpha]
Medium
Report
Clene launches $7.3M registered direct offering [Seeking Alpha]
9/30
08:30 am
clnn
Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules
High
Report
Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules
9/26
12:09 pm
clnn
IBN Coverage: Clene (NASDAQ: CLNN) to Discuss CNM-Au8(R) Data FDA Leadership [Yahoo! Finance]
Low
Report
IBN Coverage: Clene (NASDAQ: CLNN) to Discuss CNM-Au8(R) Data FDA Leadership [Yahoo! Finance]